Chris Rocheleau, who had been COO for NBAA, has moved back to the FAA to fill the deputy administrator's position vacated earlier this month.

On January 22, the US Senate Committee on Commerce, Science, and Transportation approved Duffy’s advancement to the Full ...

According to a report by The Air Current, citing multiple people familiar with the matter, Rocheleau was sworn in as the new ...

WASHINGTON — President-elect Donald Trump's nominee to head the Transportation Department said Boeing needs "tough love" to ...

A former Federal Aviation Administration official is expected to return to the agency to lead it on an interim basis. Incoming Trump administration officials are expected to name Chris Rocheleau as ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

Scientists and journalists share a core belief in questioning, observing and verifying to reach the truth. Science News reports on crucial research and discovery across science disciplines. We ...

Gilbert Flores/Billboard via Getty Chris Olsen opened up about his terrifying experience on a New York City subway this New Year's Day. On Wednesday, Jan. 1, the influencer posted a video on ...

CHRIS DOBEY'S darts career reached new heights in 2023 when he became Masters champion. His 2024 isn't going too badly either, having hit a nine-darter and won three Players Championships so far ...

In August 2005, years before he was an executive at a cybersecurity company, Chris Wade was vacationing at a casino in Las Vegas, planning to meet an associate who was supposed to hand him an ...

Chris Pula, the gregarious movie marketing executive who served stints at New Line, Warner Bros, Fox and Disney and created groundbreaking campaigns for movies from Se7en to The Mask, Dumb and ...

The FDA has approved an injectable version of the cancer drug Opdivo by Bristol Myers Squibb. Meanwhile, Axsome's Alzheimer's drug AXS-05 had mixed results in trials. Roche's CEO confirmed no job cuts ...